ESTRO 2024 - Abstract Book

S454

Clinical - Breast

ESTRO 2024

2. Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet. 2020;395(10237):1613-1626.

3. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Longterm results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513-520.

4. Ishihara T, Yoden E, Konishi K, Nagase N, Yoshida K, Kurebayashi J, et al. Long-term outcome of hypofractionated radiotherapy to the whole breast of Japanese women after breast-conserving surgery. Breast Cancer. 2014;21(1):40 46 5. Bentzen S, Agrawal R, Aird E, Barrett J, Barrett-Lee P, Bliss J, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet Oncology. 2008;9(4):331-341 6. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow up results of two randomised controlled trials. The Lancet Oncology. 2013;14(11):1086-1094.

7. Trialists' Group TS. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet. 2008;371(9618):1098-1107.

8. Hathout L, Hijal T, Théberge V, Fortin B, Vulpe H, Hogue JC, et al. Hypofractionated radiation therapy for breast ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013;87(5):1058-1063.

9. Ko DHI, Norriss A, Harrington CR, Robinson BA, James ML. Hypofractionated radiation treatment following mastectomy in early breast cancer: The Christchurch experience. J Med Imaging Radiat Oncol. 2015;59(2):243-247

9. Lalani N, Paszat L, Sutradhar R, Thiruchelvam D, Nofech-Mozes S, Hanna W, et al. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2014;90(5):1017-1024 10. Kim JY, Jung SY, Lee S, Kang HS, Lee ES, Park IH, et al. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early stage breast cancer. Int J Radiat Oncol Biol Phys. 2013;87(5):1037-1042. 11. START Trialists' Group; Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008 Mar 29;371(9618):1098-107. 12. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, Haviland J, Bentzen SM, Yarnold JR. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006 Jun;7(6):467-71. Erratum in: Lancet Oncol. 2006 Aug;7(8):620.